ABSTRACT. The distribution of amyloid deposits was histopathologically and immunohistochemically examined in 25 cows aged 5 to 10 years that had been diagnosed with systemic AA amyloidosis. This examination revealed that amyloid deposits were also present in the hypophysis, ovary, uterus, mammary gland and skeletal muscle, in addition to the liver, kidney, spleen, pancreas, thyroid gland, adrenal gland, gastrointestinal mucosa, heart, lung and lymph nodes. The examined cows tended to have chronic inflammations, including chronic mastitis (six cases) or chronic pneumonia (four cases), which is thought of as a causative agent of AA amyloidosis. In contrast, five cases did not exhibit any chronic inflammation.
Amyloidosis is a general term describing a group of diseases characterized by extracellular deposition of amyloid, in the form of ultrastructurally similar but biochemically distinct proteins, in various organs and tissues [3, 12] . In animals, at least eight different amyloid precursors have been described. The AA form of amyloid is derived from an acute-phase protein called serum amyloid A (SAA) that normally plays a role in cholesterol transport [9] and as a chemoattractant in the inflammatory process [2] . AA amyloid is the most frequently found amyloid in animals [7, 10, 17] . When the blood concentration of SAA is increased, typically as a result of chronic inflammation, certain isoforms of SAA are partially cleaved into fragments that have an increased propensity to form fibrillar aggregates (amyloid). This sequence of reactions results in the systemic deposit of amyloid, mainly in the kidney, liver, spleen and intestine [7, 12] . Recently, it has been reported that AA amyloidosis in mice is induced by the administration of amyloid enhancing factor (AEF), including AA amyloid fibrils, when there is concurrent inflammatory stimulation [4, 11] . In cattle, there have been many reported cases of amyloidosis [5, 6, 8, [12] [13] [14] [15] . However, the distribution of amyloid deposition has not been described across the entire body. It is necessary to clarify the distribution of amyloid deposition in cow affected with AA amyloidosis from a point of view of public health, although it is unclear whether AA amyloidosis in cows could be induced by AEF administration and is doubtful AA amyloidosis in cow should be take up a public health problem. In this study, we examined 25 cows diagnosed with systemic AA amyloidosis to determine how amyloid deposits are distributed through the body, using the method of immunohistochemical examination.
Tissue specimens from 25 Holstein-Friesian cows aged 5 to 10 years that had been diagnosed with systemic amyloidosis by routine histopathological examination were examined ( µm. Dewaxed sections were stained with hematoxylin and eosin (HE). Also, serial sections were stained with Congo red. For immunohistochemistry (IHC), dewaxed sections were subjected to the strept-avidin-biotin complex peroxidase (SAB-PO) method using a HISTOFINE SAB-PO kit (Nichirei, Japan) with 0.1% Actinase E pretreatment at room temperature for 10 min. The antibody used in this study was monoclonal anti-AA amyloid (1:1000, Incubated 30 min at room temperature, KYOWA, Japan). Amyloid was observed by HE stain as extracellular eosinophilic deposits that were consistently positive for Congo red stain. Immunohistochemically, extracellular and vascular deposits were clearly demonstrated even where deposits were not observed by HE. The distribution of amyloid deposits is summarized in Table 1 . The presence of amyloid deposits was mainly detected in the liver, kidney (Figs. 1 and 2), spleen, pancreas, thyroid gland, adrenal gland, and gastrointestinal mucosa (Table 1) . Amyloid deposits were also observed in the hypophysis (Figs. 3 and 4), ovary ( Table 1) . Hepatic amyloid deposits were located in the space of Disse with partial pressure atrophy of the surrounding hepatocytes. In the kidney, lesions were most notable in the glomeruli (Figs. 1 and 2) and medulla interstitium. In the spleen, deposits involved the wall of the venous sinus (red pulp). In the lung, ovary and uterus, the deposit was only seen in the blood vessels (Fig. 5 ). In the hypophysis (Figs. 3 and 4) , small and large intestine, mammary gland, and skeletal muscle (Fig. 7) , deposits were mostly observed in the blood vessels with minor interstitial deposits. In the mammary gland, interstitial deposits were clearly demonstrated on the rim of acini by IHC (Fig. 6 ) even where deposits were not observed by HE. The amyloid deposits in the mammary gland and skeletal muscle were less significant than in the other organs. There were no amyloid deposits in the nervous system. In some cases (for a total of 13), mastitis (six cases), pneumonia (four cases), arthritis (two cases), cystitis (two cases), liver abscesses (two cases), and endometritis (one case) were observed as concurrent chronic inflammatory lesions. In five cases, there were no chronic inflammatory lesions in the examined organs including the mammary gland, lung, uterus and joints.
This study presents a detailed distribution of amyloid deposits related to systemic AA amyloidosis in cows. Amyloid deposits were observed in the genital organs, mammary gland, and skeletal muscle, in addition to the liver, kidney, spleen, endocrine organs, and gastrointestinal mucosa, where deposits have been previously described. IHC analyses using monoclonal antibody against AA amyloid reacted specifically with amyloid deposits in many of the cow organs.
The present study demonstrates that systemic amyloidosis in cows tends to develop after five years of age. It seemed to be related to the onset of systemic amyloidosis and aging, but the distribution and degree of the amyloid deposits were not correlated with aging. AA amyloidosis characteristically develops in humans and animals as a consequence of a long-standing chronic infectious or inflammatory process [12] . It has been reported that gangrenous pneumonia seems to be relatively high in AA amyloidosis of adult sheep [12] . The cows we examined tended to have chronic mastitis and pneumonia as concurrent inflammatory lesions. Amyloidosis tends to be more frequent in cows than in other animals. This seems to result from a disposition of cows to catch productive disorders, including mastitis and endometritis, more frequently than other animals. However, there were also five cases without any chronic inflammatory lesions. There was no difference of the pattern of amyloid distribution between this five cases and cases with chronic inflammatory lesions. We could not clarify the relationship between the development of systemic Table1. Immunohistochemical distribution of amyloid deposition in cows diagnosed as systemic AA amyloidosis
A, P 9 CIL: Chronic inflammatory lesions. P: Pneumonia, E: Endometritis, M: Mastitis, C: Cystitis, L: Liver abscesses, A: arthritis, -: There were no macroscopic and histologic lesions of chronic inflammation in the examined organs including mammary gland, lung, uterus and joint, Unknown: Not done at all object organs. +: Positive, -: Negative, •: Not done.
N o . C I L A g e ( y ) L i v e r S p l e e n K i d n e y H e a r t L u n g A d r e n a l g l a n d P a n c r e a s T h y r o i d g l a n d H y p o p h y s i s Recently, it has been reported that AA amyloidosis in mice is induced by the administration of AEF, including AA amyloid fibrils, when there is concurrent inflammatory stimulation [4, 11] . Fibrillogenesis of AA amyloid occurs in a two-stage or biphasic process [4, 16] . The first phase involves the synthesis of precursor proteins that accumulate in sufficient quantities to initiate an amyloid deposit. This phase, known as the preamyloid phase, continues for a period ranging from several days to several years without an actual amyloid deposit. The duration of the preamyloid phase depends on the inflammatory stimuli and the level of SAA [4] . The second phase, called the amyloid phase, is thought to result from the generation of a nidus or fibrillar network onto which amyloid can be deposited [4] . The preamyloid phase of experimentally induced murine AA amyloidosis can be greatly shortened in recipient animals when AEF is administered by intravenous or intraperitoneal injection, or by ingestion concomitant with an inflammatory episode [1, 7] . It was reported that AA amyloid deposition in mice can also be accelerated by oral administration of semipurified amyloid fibrils with concurrent inflammatory stimulation [4] . It is possible that under certain inflammatory conditions, oral administration of exogenous amyloid fibrils may increase the onset of AA amyloidosis in cows just as in mice. It is unclear whether AA amyloidosis in cows could be induced by AEF administration with inflammatory stimulation. Further studies, including the experimental reproduction of systemic AA amyloidosis in cows, are needed to clarify amyloidogenesis in cows and the relationship between AA amyloidosis and AEF. 
